High-Throughput Data
Management for
Biopharmaceutical Development

Core Capabilities

The biopharmaceutical market is growing at a previously unseen pace, and so should
you. High-Throughput technologies have shifted the bottleneck from capacity to
run experiments to the ability to handle the large volumes of data generated.

With a CAGR of 13%, the CLD market is expected to turn over $7.5 billion by 2023. Are you keeping pace?

Stop transcribing. You’re losing time

Sustainable high-throughput process development doesn’t mean working harder or running faster. It means progression with minimum waste of time, energy and resources. It means letting your data do the job for you. So stop being a data clerk.

Improved data traceability for faster regulatory approval

With an integrated and automated informatics platform you can ensure full data traceability to optimize critical quality attributes and better understand all process parameters.

Simplify technology transfer and reporting

Problems scale-up as you scale-up. Failure to select the best clones and critical process parameters amplify in production, and failure at tech transfer cause significant and costly delays.

Faster to first in human – and to market

Time is lost by use of legacy systems. Problems increase exponentially at high-throughput. Unless you deploy a high-throughput data management strategy to make your data dance.